Bradley Burnam Reports 52.76% Controlling Stake in Turn Therapeutics Inc. (TTRX)

On April 6, 2026, Bradley Burnam filed a Schedule 13G reporting a significant majority ownership stake in Turn Therapeutics Inc. (TTRX). As of the event date of December 31, 2025, Burnam beneficially owns 15,716,260 shares of common stock, representing 52.76% of the company's outstanding shares. This position includes shares held of record by BEB Holdings, LLC, of which Burnam is the sole member, as well as stock options exercisable within 60 days of April 2, 2026. The filing indicates that Burnam holds sole voting and dispositive power over the reported shares. The ownership percentage is calculated based on 29,788,040 shares of common stock outstanding as of March 30, 2026. This filing establishes Burnam as a controlling shareholder of Turn Therapeutics Inc., a Westlake Village-based company. The disclosure was made pursuant to Rule 13d-1(d), typically used by founders or early investors who acquired shares prior to the company's registration.